Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-08 Option Award | 2022-06-10 4:11 pm | N/A 2032-06-08 | NovoCure Ltd | NVCR | Hung David Director | 6,777 | $0 | 13,491 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 2:29 pm | N/A 2032-02-27 | Nuvation Bio Inc. | NUVB | Hung David CEO 10% Owner | 2,000,000 | $0 | 60,646,800 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-11 4:19 pm | N/A 2031-06-09 | NovoCure Ltd | NVCR | Hung David Director | 2,313 | $0 | 8,213 (Direct) | View |
| 2021-03-09 Option Award | 2021-03-11 4:35 pm | N/A 2031-03-08 | Nuvation Bio Inc. | NUVB | Hung David CEO 10% Owner | 390,225 | $0 | 390,225 (Direct) | View |
| 2021-02-10 Option Award | 2021-02-12 5:45 pm | N/A N/A | Nuvation Bio Inc. | NUVB | Hung David CEO 10% Owner | 57,645,012 | $0 | 59,645,012 (Direct) | View |
| 2021-02-10 Option Award | 2021-02-12 5:45 pm | N/A N/A | Nuvation Bio Inc. | NUVB | Hung David CEO 10% Owner | 2,000,000 | $10 | 59,645,012 (Direct) | View |
| 2021-02-10 Ownership | 2021-02-12 5:30 pm | N/A N/A | Nuvation Bio Inc. | NUVB | Hung David CEO 10% Owner | 0 | $0 | 0 (Direct) | View |
| 2020-07-01 Disposition | 2020-07-06 9:53 pm | N/A N/A | ARYA SCIENCES ACQUISITION CORP. | ARYA | Hung David Director | 30,000 | $0 | 0 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:07 pm | N/A 2030-06-10 | NovoCure Ltd | NVCR | Hung David Director | 7,642 | $0 | 11,001 (Direct) | View |
| 2020-05-26 Option Award | 2020-05-27 4:42 pm | N/A 2030-05-26 | ESTABLISHMENT LABS HOLDINGS Inc | ESTA | Hung David Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2019-06-03 Option Award | 2019-06-05 4:37 pm | N/A 2029-06-03 | ESTABLISHMENT LABS HOLDINGS Inc | ESTA | Hung David Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2019-05-22 Option Award | 2019-05-24 4:24 pm | N/A 2029-05-22 | NovoCure Ltd | NVCR | Hung David Director | 9,699 | $0 | 9,699 (Direct) | View |
| 2018-10-05 Ownership | 2018-10-05 4:36 pm | N/A N/A | ARYA SCIENCES ACQUISITION CORP. | ARYA | Hung David Director | 0 | $0 | 30,000 (Direct) | View |
| 2018-07-18 Ownership | 2018-07-18 5:43 pm | N/A 2026-08-31 | ESTABLISHMENT LABS HOLDINGS Inc | ESTA | Hung David Director | 0 | $0 | 36,780 (Direct) | View |
| 2018-05-31 Ownership | 2018-06-11 4:20 pm | N/A 2028-05-31 | NovoCure Ltd | NVCR | Hung David Director | 0 | $0 | 45,137 (Direct) | View |
| 2018-05-31 Option Award | 2018-06-04 9:42 pm | N/A 2028-05-31 | NovoCure Ltd | NVCR | Hung David Director | 45,137 | $0 | 45,137 (Direct) | View |
| 2017-12-29 Exercise | 2018-01-03 08:48 am | N/A 2027-12-29 | Axovant Sciences Ltd. | AXON | Hung David Principal Executive Officer | 2,000,000 | $0 | 2,000,000 (Direct) | View |